Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection

This publication has 10 references indexed in Scilit:

• Adverse effects of antiretroviral therapy
  The Lancet, 2000
• HIV protease inhibitors block adipogenesis and increase lipolysis in vitro
  Antiviral Research, 2000
• Amprenavir in Combination with Lamivudine and Zidovudine versus Lamivudine and Zidovudine Alone in HIV-1-Infected Antiretroviral-Naive Adults
  Antiviral Therapy, 2000
• Stimulation of vitamin A1 acid signaling by the HIV protease inhibitor indinavir
  Biochemical Pharmacology, 2000
• Alopecia Associated with Indinavir Therapy
  New England Journal of Medicine, 1999
• Paronychia and Pyogenic Granuloma of the Great Toes in Patients Treated with Indinavir
  New England Journal of Medicine, 1998
• Protease inhibitors for the treatment of human immunodeficiency virus infection
  American Journal of Health-System Pharmacy, 1998
• Propylene Glycol: The Safe Diluent that Continues to Cause Harm
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1996
• In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease
  Journal of Virology, 1995
• Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors
  Antimicrobial Agents and Chemotherapy, 1995